(Q42169148)

17 October 2017

Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase (English)

1 reference

17 October 2017

0 references

0 references

0 references

Robert A Frost

1

1 reference

PubMed ID

12842862

17 October 2017

Gerald J Nystrom

series ordinal

2

1 reference

PubMed ID

12842862

17 October 2017

Charles H Lang

series ordinal

3

1 reference

17 October 2017

3 July 2003

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

17 October 2017

1 reference

17 October 2017

285

1 reference

17 October 2017

R1153-64

1 reference

17 October 2017

5

1 reference

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

17 October 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Purification of mouse primary myoblasts based on alpha 7 integrin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Quinone reductase inhibitors block SAPK/JNK and NFkappaB pathways and potentiate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Transcription factors c-Jun/activator protein-1 and nuclear factor-kappa B in oxidative stress response in mitochondrial diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Tumor Necrosis Factor-α Decreases Insulin-Like Growth Factor-I Messenger Ribonucleic Acid Expression in C2C12 Myoblasts via a Jun N-Terminal Kinase Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Nuclear factor-kappa B-independent regulation of lipopolysaccharide-mediated interleukin-6 biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

MEKK3 interacts with the PA28 gamma regulatory subunit of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

IL-1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Effect of transforming growth factor-beta1 on interleukin-6 secretion in human myoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Interleukin-6 response to exercise and high-altitude exposure: influence of alpha-adrenergic blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Proteasome inhibitors induce heat shock response and increase IL-6 expression in human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Cytokines and the hepatic acute-phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Plasma interleukin-6 during strenuous exercise: role of epinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Signaling by distinct classes of phosphoinositide 3-kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Central and peripheral catecholamines regulate the exercise-induced elevation of plasma interleukin 6 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

In Vivo Expression of Proinflammatory Mediators in the Adult Heart after Endotoxin Administration: The Role of Toll‐Like Receptor–4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00164.2003

10.1152/AJPREGU.00164.2003

21 January 2018

Identifiers

DOI

1 reference

17 October 2017

1 reference

PubMed ID

12842862